{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:15:01Z","timestamp":1777374901195,"version":"3.51.4"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1097\/mph.0b013e3181ec0f13","type":"journal-article","created":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T10:05:07Z","timestamp":1285927507000},"page":"601-605","source":"Crossref","is-referenced-by-count":57,"title":["The Safety, Tolerability, and Efficacy of a Liquid Formulation of Deferiprone in Young Children With Transfusional Iron Overload"],"prefix":"10.1097","volume":"32","author":[{"given":"Moshen","family":"El Alfy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teny Tjitra","family":"Sari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan Lee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Tricta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"El-Beshlawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210227","article-title":"Clinical Study Report LA-01: Randomized Trial of Deferiprone (L1) and Deferoxamine in Thalassemia Major","year":"1998"},{"key":"R2-6-20210227","article-title":"Clinical Study Report LA-02: Trial of Deferiprone in Thalassemia","year":"1998"},{"key":"R3-6-20210227","article-title":"Clinical Study Report LA-03: The Long Term Efficacy and Safety of Deferiprone in Patients with Thalassemia","year":"2006"},{"key":"R4-6-20210227","article-title":"Clinical Study Report LA-02\/06: Clinical Study Report for 7 Years of Therapy with Ferriprox in Patients Participating in Study LA-02\/06","year":"2006"},{"key":"R5-6-20210227","article-title":"Clinical Study Report LA-12: Comparative Data on Survival and Heart Failure in Thalassemia Patients Completing 4 or More Years of Therapy with Deferoxamine and Deferiprone. Follow-up March 2001. Specific Obligation to the CPMP","year":"2001"},{"key":"R7-6-20210227","first-page":"406a","article-title":"Deferiprone and Neutropenia; Incidence and characteristics in a long-term safety study","volume":"94","author":"Cohen","year":"1999","journal-title":"Blood"},{"key":"R8-6-20210227","article-title":"Clinical Study Report LA-21 BE: Randomized, Open Label, Comparative, Two-way Crossover Bioavailability Study of Deferiprone Oral Solution and Ferriprox (deferiprone) Tablets Under Fasting Conditions","year":"2005"},{"key":"R9-6-20210227","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1055\/s-2007-973845","article-title":"Recent developments in iron chelation therapy","volume":"219","author":"Cario","year":"2007","journal-title":"Klin Padiatr"},{"key":"R10-6-20210227","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1182\/blood-2002-10-3280","article-title":"Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone","volume":"102","author":"Cohen","year":"2003","journal-title":"Blood"},{"key":"R12-6-20210227","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-2141.2000.01866.x","article-title":"Safety profile of the oral iron chelator deferiprone: a multicentre study","volume":"108","author":"Cohen","year":"2000","journal-title":"Br J Haematol"},{"key":"R15-6-20210227","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/14740338.6.3.235","article-title":"Deferasirox: uncertain future following renal failure fatalities, agranulocytosis and other toxicities","volume":"6","author":"Kontoghiorghes","year":"2007","journal-title":"Expert Opin Drug Saf"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0b013e3181ec0f13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:08:22Z","timestamp":1620965302000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201011000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e3181ec0f13","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}